Your browser doesn't support javascript.
loading
Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.
Kotlov, Nikita; Shaposhnikov, Kirill; Tazearslan, Cagdas; Chasse, Madison; Baisangurov, Artur; Podsvirova, Svetlana; Fernandez, Dawn; Abdou, Mary; Kaneunyenye, Leznath; Morgan, Kelley; Cheremushkin, Ilya; Zemskiy, Pavel; Chelushkin, Maxim; Sorokina, Maria; Belova, Ekaterina; Khorkova, Svetlana; Lozinsky, Yaroslav; Nuzhdina, Katerina; Vasileva, Elena; Kravchenko, Dmitry; Suryamohan, Kushal; Nomie, Krystle; Curran, John; Fowler, Nathan; Bagaev, Alexander.
Afiliação
  • Kotlov N; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Shaposhnikov K; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Tazearslan C; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Chasse M; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Baisangurov A; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Podsvirova S; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Fernandez D; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Abdou M; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Kaneunyenye L; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Morgan K; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Cheremushkin I; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Zemskiy P; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Chelushkin M; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Sorokina M; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Belova E; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Khorkova S; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Lozinsky Y; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Nuzhdina K; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Vasileva E; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Kravchenko D; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Suryamohan K; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Nomie K; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Curran J; BostonGene, Corp., Waltham, MA, 02453, USA.
  • Fowler N; BostonGene, Corp., Waltham, MA, 02453, USA. nathan.fowler@bostongene.com.
  • Bagaev A; BostonGene, Corp., Waltham, MA, 02453, USA.
Commun Biol ; 7(1): 392, 2024 Mar 30.
Article em En | MEDLINE | ID: mdl-38555407
ABSTRACT
With the increased use of gene expression profiling for personalized oncology, optimized RNA sequencing (RNA-seq) protocols and algorithms are necessary to provide comparable expression measurements between exome capture (EC)-based and poly-A RNA-seq. Here, we developed and optimized an EC-based protocol for processing formalin-fixed, paraffin-embedded samples and a machine-learning algorithm, Procrustes, to overcome batch effects across RNA-seq data obtained using different sample preparation protocols like EC-based or poly-A RNA-seq protocols. Applying Procrustes to samples processed using EC and poly-A RNA-seq protocols showed the expression of 61% of genes (N = 20,062) to correlate across both protocols (concordance correlation coefficient > 0.8, versus 26% before transformation by Procrustes), including 84% of cancer-specific and cancer microenvironment-related genes (versus 36% before applying Procrustes; N = 1,438). Benchmarking analyses also showed Procrustes to outperform other batch correction methods. Finally, we showed that Procrustes can project RNA-seq data for a single sample to a larger cohort of RNA-seq data. Future application of Procrustes will enable direct gene expression analysis for single tumor samples to support gene expression-based treatment decisions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA / Perfilação da Expressão Gênica Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: RNA / Perfilação da Expressão Gênica Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2024 Tipo de documento: Article